RxDoctor Payments Data

Britni Browning, PA

Physician Assistant · Fairbanks, AKNPI 1215329529

Payments from drug & device makers

$454in general payments, 2019–2025

Across 18 payments — averaging $25.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$79
  • Pharmacyclics LLC, An Abbvie Company$69
  • Janssen Scientific Affairs, LLC$61
  • Johnson & Johnson$47
  • Celltrion USA Inc.$34
  • Genentech, Inc.$33
  • plus $131 from 7 others

What the payments were for

  • Food & beverage$38585%
  • Education$6915%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$454 in reported general payments places this provider in the 70th percentile of 365 physician assistant providers in Alaska.

See all physician assistant providers in Alaska

Medicare billing

Part B allowed, 2024
$2,840,408
Medicare patients
278
Services billed
118,036

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CalquenceAcalabrutinib Maleate20$429,344
LynparzaOlaparib20$329,115
TasignaNilotinib Hcl11$268,927
JaypircaPirtobrutinib12$262,772
IclusigPonatinib Hcl12$253,068
ErleadaApalutamide17$251,508
VenclextaVenetoclax21$114,575
EliquisApixaban27$21,735
XareltoRivaroxaban12$6,879
Morphine Sulfate ErMorphine Sulfate27$619
Hydroxyurea11$600
Anastrozole34$450
Oxycodone Hcl30$375
Prochlorperazine Maleate18$370
Pantoprazole Sodium26$227

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaCalquence, Lynparza$79$758,45940 claims
Johnson & JohnsonErleada, Xarelto$47$258,38729 claims
AbbVieVenclexta$26$114,57521 claims
PfizerEliquis$22$21,73527 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 365 physician assistant providers in Alaska.

Other physician assistant in Fairbanks

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →